tyrosine and 2,4-thiazolidinedione

tyrosine has been researched along with 2,4-thiazolidinedione in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anai, M; Ando, K; Asano, T; Chiba, Y; Fujishiro, M; Fujita, T; Fukushima, Y; Inukai, K; Kikuchi, M; Ogihara, T; Onishi, Y; Ono, H; Sakoda, H; Sekine, N; Shojima, N1
Dey, CS; Kumar, N1
Accili, D; Carnemolla, R; Han, S; Liang, CP; Okamoto, H; Tabas, I; Tall, AR1
Grommes, C; Heneka, MT; Landreth, GE; Schlegel, U1

Other Studies

4 other study(ies) available for tyrosine and 2,4-thiazolidinedione

ArticleYear
Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats.
    Diabetes, 2001, Volume: 50, Issue:3

    Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Deoxyglucose; Diet, Sodium-Restricted; Enzyme Activation; Glucose Clamp Technique; Glycogen Synthase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinases; In Vitro Techniques; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Liver; Male; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Signal Transduction; Thiazoles; Thiazolidinediones; Tyrosine

2001
Development of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells.
    Biochemical pharmacology, 2003, Jan-15, Volume: 65, Issue:2

    Topics: Animals; Biological Transport; Cell Differentiation; Cells, Cultured; Culture Media, Serum-Free; Deoxyglucose; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Mice; Muscle, Skeletal; Myoblasts; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Pioglitazone; Receptor, Insulin; Rosiglitazone; Thiazoles; Thiazolidinediones; Tyrosine

2003
Increased CD36 protein as a response to defective insulin signaling in macrophages.
    The Journal of clinical investigation, 2004, Volume: 113, Issue:5

    Topics: Animals; Blotting, Northern; Blotting, Western; CD36 Antigens; Chromones; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Foam Cells; Glutathione; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipoproteins, LDL; Macrophages; Mice; Mice, Inbred C57BL; Mice, Obese; Morpholines; Oxygen; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Binding; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Signal Transduction; Thiazolidinediones; Time Factors; Transcription Factors; Transcription, Genetic; Tyrosine

2004
The nonthiazolidinedione tyrosine-based peroxisome proliferator-activated receptor gamma ligand GW7845 induces apoptosis and limits migration and invasion of rat and human glioma cells.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 313, Issue:2

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Migration Inhibition; Cell Movement; Cell Survival; Glioma; Humans; Ligands; Oxazoles; PPAR gamma; Rats; Thiazolidinediones; Tyrosine

2005